AmeriPharm

Hi-Tech Pharmaceuticals adds (4) more Stokes 328 tablet presses to increase our ability to make more large tablets for our Cyclosome ® Technology  and Guaifenesin OTC drug  products. Two presses will be dedicated to our revolutionary weight management product --SLIMAGLUTIDE ® and Cyclosome ® products. The other two presses will be for our Ameripharm brand of OTC products and to partner with store brand products to sell a high quality generic version of cough and mucus fighter Mucinex tablets. The treatment, which will boster the availability of what is expected to be a range of new, generic store brand cough and mucus-suppressant products, is packaged and will be sold under retailers' own labels and our Ameripharm line of OTC products. The OTC product (guaifenesin 1200-mg and dextromethorphan HBr 60-mg extended-release tablets) is indicated to control coughs and break up mucus in order to make coughs more productive. The over-the-counter cold and flu market is sizeable. Total revenue for cough and cold remedies is over USD 12 billion, and it could grow annually by 7%, according to Statista. Upper respiratory treatments are the single biggest over-the-counter drug category, according to the nonprofit Consumer Healthcare Protection Association. "This is another great example of the Hi-Tech and Ameripharm teams continuing to leverage their unique capabilities in providing U.S. consumers greater savings and access to key new store brand over-the-counter products," Hi-Tech CEO Jared Wheat said in the release. "These new store brand products, which are equivalent to the Mucinex brand, are an important offering to our customers as they deliver  high-quality, value alternative available in the marketplace with significant volumes."